“More Evidence that Antipsychotics Shrink the Brain”

8
103

A review of 18 imaging studies finds that brain matter loss in patients diagnosed with schizophrenia is correlated with antipsychotic use, according to Psych Central.  The analysis suggests that the continued use of antipsychotics is linked with progressive cortical gray matter loss.

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time

8 COMMENTS

  1. Another one…
    The fat lady has sung. But apparently it’s OK to cause brain damage in “schizophrenics” and other “human trash” – they are not good little robots so they have no worth in society. Who cares if they only get worse and end up dying 25 years too early.

    • Yes, I thought this was reported back in 2011 or 2013? I did think it so psychiatric to claim that since they found the brain damage less, not non-existent, with the second generation antipsychotics than the first, the second generation antipsychotics are “neuroprotective.” No they’re not, they too are damaging the brain.

  2. Research has shown that alcohol dependency damages the brain and that valium dependency damages the brain, so it’s not surprising that longterm “antipsychotic” dosing damages the brain.

    I think it’s part of the “organised denial” system that this fact is taking so long to be scientifically identified.

    http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20(General%20Monographs-%20M)/MODECATE.html

    Manufacturers’ Warnings In Clinical States:
    “…..The prevalence of TD greatly varies; when the mildest symptoms are included, prevalence can be 70%….”

  3. Yes, the end result of this will be more Abilify. What a hideous drug. The FDA was wrong to allow it to be named Abilify, too. Obviously it should be Disabilify.

    There’s a clinical trial for a drug that’s suppose to help with tardive dyskinesia. Look how they omit mention of the cause and the name tardive dyskinesia

    https://www.kinect4study.com/
    Do involuntary body movements have a hold on you?

    If you or a loved one suffer from bipolar disorder, mood disorder, schizoaffective disorder, or schizophrenia – and are experiencing involuntary movements in your face or other parts of your body – the Kinect 4 Study may help.

    Individuals 18 to 85 years old will be evaluated to determine their eligibility. Those who qualify will receive:

    Study medication for the study treatment period of 48 weeks.
    Study-related medical exams and lab tests at no charge.
    Regular general health check-ups and monitoring of TD symptoms.
    Compensation for time and travel may also be available.

LEAVE A REPLY